Sustained Remission with the Combination Biologic Doublet of Lenalidomide Plus Rituximab As Initial Treatment for Mantle Cell Lymphoma: A Multi-Center Phase II Study Report

Jia Ruan, John P. Leonard, Bijal Shah et al.|Blood|2014

Cited by 18